CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo

Musaed M. Alshahrani, Eunice Yang, Jana Yip, Simona Ghanem, Simon L. Abdallah, Anthony M. De Angelis, Cindy J. O'Malley, Fatemeh Moheimani, Sonia M. Najjar, Denise E. Jackson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Carcinoembryonic antigen-related cell adhesion molecule-2 (CEACAM2) is a cell-surface glycoprotein expressed on blood, epithelial, and vascular cells. CEACAM2 possesses adhesive and signaling properties mediated by immunoreceptor tyrosine-based inhibitory motifs. In this study, we demonstrate that CEACAM2 is expressed on the surface and in intracellular pools of platelets. Functional studies of platelets from Ceacam2-/--deficient mice (Cc2-/-) revealed that CEACAM2 serves to negatively regulate collagen glycoprotein VI (platelet) (GPVI)-FcRγ-chain and the C-type lectinlike receptor 2 (CLEC-2) signaling. Cc2-/-platelets displayed enhanced GPVI and CLEC-2-selective ligands, collagen-related peptide (CRP), collagen, and rhodocytin (Rhod)-mediated platelet aggregation. They also exhibited increased adhesion on type I collagen, and hyperresponsive CRP and CLEC-2-induced a and dense granule release compared with wild-type platelets. Furthermore, using intravital microscopy to ferric chloride (FeCl3)-injured mesenteric arterioles and laser-induced injury of cremaster muscle arterioles, we herein show that thrombi formed in Cc2-/-mice were larger and more stable than wild-type controls in vivo. Thus, CEACAM2 is a novel platelet immunoreceptor that acts as a negative regulator of platelet GPVI-collagen interactions and of ITAM receptor CLEC-2 pathways.

Original languageEnglish
Pages (from-to)2431-2441
Number of pages11
JournalBlood
Volume124
Issue number15
DOIs
Publication statusPublished - 9 Oct 2014
Externally publishedYes

Fingerprint

Bearings (structural)
Carcinoembryonic Antigen
Cell Adhesion Molecules
Platelets
Thrombosis
Blood Platelets
Growth
Collagen
Arterioles
Abdominal Muscles
Membrane Glycoproteins
Collagen Type I
Platelet Aggregation
Adhesives
Blood Vessels
Tyrosine
In Vitro Techniques
Lasers
Epithelial Cells
Muscle

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Alshahrani, M. M., Yang, E., Yip, J., Ghanem, S., Abdallah, S. L., De Angelis, A. M., ... Jackson, D. E. (2014). CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. Blood, 124(15), 2431-2441. https://doi.org/10.1182/blood-2014-04-569707

CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. / Alshahrani, Musaed M.; Yang, Eunice; Yip, Jana; Ghanem, Simona; Abdallah, Simon L.; De Angelis, Anthony M.; O'Malley, Cindy J.; Moheimani, Fatemeh; Najjar, Sonia M.; Jackson, Denise E.

In: Blood, Vol. 124, No. 15, 09.10.2014, p. 2431-2441.

Research output: Contribution to journalArticle

Alshahrani, MM, Yang, E, Yip, J, Ghanem, S, Abdallah, SL, De Angelis, AM, O'Malley, CJ, Moheimani, F, Najjar, SM & Jackson, DE 2014, 'CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo', Blood, vol. 124, no. 15, pp. 2431-2441. https://doi.org/10.1182/blood-2014-04-569707
Alshahrani, Musaed M. ; Yang, Eunice ; Yip, Jana ; Ghanem, Simona ; Abdallah, Simon L. ; De Angelis, Anthony M. ; O'Malley, Cindy J. ; Moheimani, Fatemeh ; Najjar, Sonia M. ; Jackson, Denise E. / CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. In: Blood. 2014 ; Vol. 124, No. 15. pp. 2431-2441.
@article{6b37cd87a4db4ed58db850f546b5b5c6,
title = "CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo",
abstract = "Carcinoembryonic antigen-related cell adhesion molecule-2 (CEACAM2) is a cell-surface glycoprotein expressed on blood, epithelial, and vascular cells. CEACAM2 possesses adhesive and signaling properties mediated by immunoreceptor tyrosine-based inhibitory motifs. In this study, we demonstrate that CEACAM2 is expressed on the surface and in intracellular pools of platelets. Functional studies of platelets from Ceacam2-/--deficient mice (Cc2-/-) revealed that CEACAM2 serves to negatively regulate collagen glycoprotein VI (platelet) (GPVI)-FcRγ-chain and the C-type lectinlike receptor 2 (CLEC-2) signaling. Cc2-/-platelets displayed enhanced GPVI and CLEC-2-selective ligands, collagen-related peptide (CRP), collagen, and rhodocytin (Rhod)-mediated platelet aggregation. They also exhibited increased adhesion on type I collagen, and hyperresponsive CRP and CLEC-2-induced a and dense granule release compared with wild-type platelets. Furthermore, using intravital microscopy to ferric chloride (FeCl3)-injured mesenteric arterioles and laser-induced injury of cremaster muscle arterioles, we herein show that thrombi formed in Cc2-/-mice were larger and more stable than wild-type controls in vivo. Thus, CEACAM2 is a novel platelet immunoreceptor that acts as a negative regulator of platelet GPVI-collagen interactions and of ITAM receptor CLEC-2 pathways.",
author = "Alshahrani, {Musaed M.} and Eunice Yang and Jana Yip and Simona Ghanem and Abdallah, {Simon L.} and {De Angelis}, {Anthony M.} and O'Malley, {Cindy J.} and Fatemeh Moheimani and Najjar, {Sonia M.} and Jackson, {Denise E.}",
year = "2014",
month = "10",
day = "9",
doi = "10.1182/blood-2014-04-569707",
language = "English",
volume = "124",
pages = "2431--2441",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "15",

}

TY - JOUR

T1 - CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo

AU - Alshahrani, Musaed M.

AU - Yang, Eunice

AU - Yip, Jana

AU - Ghanem, Simona

AU - Abdallah, Simon L.

AU - De Angelis, Anthony M.

AU - O'Malley, Cindy J.

AU - Moheimani, Fatemeh

AU - Najjar, Sonia M.

AU - Jackson, Denise E.

PY - 2014/10/9

Y1 - 2014/10/9

N2 - Carcinoembryonic antigen-related cell adhesion molecule-2 (CEACAM2) is a cell-surface glycoprotein expressed on blood, epithelial, and vascular cells. CEACAM2 possesses adhesive and signaling properties mediated by immunoreceptor tyrosine-based inhibitory motifs. In this study, we demonstrate that CEACAM2 is expressed on the surface and in intracellular pools of platelets. Functional studies of platelets from Ceacam2-/--deficient mice (Cc2-/-) revealed that CEACAM2 serves to negatively regulate collagen glycoprotein VI (platelet) (GPVI)-FcRγ-chain and the C-type lectinlike receptor 2 (CLEC-2) signaling. Cc2-/-platelets displayed enhanced GPVI and CLEC-2-selective ligands, collagen-related peptide (CRP), collagen, and rhodocytin (Rhod)-mediated platelet aggregation. They also exhibited increased adhesion on type I collagen, and hyperresponsive CRP and CLEC-2-induced a and dense granule release compared with wild-type platelets. Furthermore, using intravital microscopy to ferric chloride (FeCl3)-injured mesenteric arterioles and laser-induced injury of cremaster muscle arterioles, we herein show that thrombi formed in Cc2-/-mice were larger and more stable than wild-type controls in vivo. Thus, CEACAM2 is a novel platelet immunoreceptor that acts as a negative regulator of platelet GPVI-collagen interactions and of ITAM receptor CLEC-2 pathways.

AB - Carcinoembryonic antigen-related cell adhesion molecule-2 (CEACAM2) is a cell-surface glycoprotein expressed on blood, epithelial, and vascular cells. CEACAM2 possesses adhesive and signaling properties mediated by immunoreceptor tyrosine-based inhibitory motifs. In this study, we demonstrate that CEACAM2 is expressed on the surface and in intracellular pools of platelets. Functional studies of platelets from Ceacam2-/--deficient mice (Cc2-/-) revealed that CEACAM2 serves to negatively regulate collagen glycoprotein VI (platelet) (GPVI)-FcRγ-chain and the C-type lectinlike receptor 2 (CLEC-2) signaling. Cc2-/-platelets displayed enhanced GPVI and CLEC-2-selective ligands, collagen-related peptide (CRP), collagen, and rhodocytin (Rhod)-mediated platelet aggregation. They also exhibited increased adhesion on type I collagen, and hyperresponsive CRP and CLEC-2-induced a and dense granule release compared with wild-type platelets. Furthermore, using intravital microscopy to ferric chloride (FeCl3)-injured mesenteric arterioles and laser-induced injury of cremaster muscle arterioles, we herein show that thrombi formed in Cc2-/-mice were larger and more stable than wild-type controls in vivo. Thus, CEACAM2 is a novel platelet immunoreceptor that acts as a negative regulator of platelet GPVI-collagen interactions and of ITAM receptor CLEC-2 pathways.

UR - http://www.scopus.com/inward/record.url?scp=84907612583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907612583&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-04-569707

DO - 10.1182/blood-2014-04-569707

M3 - Article

VL - 124

SP - 2431

EP - 2441

JO - Blood

JF - Blood

SN - 0006-4971

IS - 15

ER -